VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts, 02130-4817, United States
Location status: Recruiting
Location contact
Elisa Ogawa, PhD MS BS
CONTACT
Elisa Ogawa, PhD MS BS
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06451874
This study will begin to evaluate personalized preventative dementia treatments for Veterans at risk for developing dementia. The investigators will target Veterans with Motoric Cognitive Risk syndrome (MCR), which is characterized by slow gait speed and cognitive concerns (e.g., problems with memory or concentrations).
Interested in participating?
Request Info65 year and older
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02130-4817, United States
Location status: Recruiting
Elisa Ogawa, PhD MS BS
CONTACT
Elisa Ogawa, PhD MS BS
PRINCIPAL_INVESTIGATOR
This study will involve therapeutic exercise treatments for Veterans with pre-clinical dementia syndrome. Participants will either participate in functional power training, music-based walking training, or a combination of both. The study will use a sequential multiple assignment, randomized trial (SMART) design. Successful completion of this study will lay the foundation for subsequent research trials, contributing to valuable evidence for personalized rehabilitation medicine for older Veterans.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive twice weekly FPT, a progressive functional-based exercises that target optimizing leg force production and leg velocity.
Participants will receive twice weekly MBDT, a technology-driven gait training that is grounded in evidence-based rehabilitation treatment, rhythmic auditory stimulation.
For non-responders who were randomized to augment treatment, they will receive combined FPT and MBDT treatment.
Time frame: Enrollment
Enrollment will be defined as the number of participants who were recruited and consented to the study.
Time frame: Baseline to end of 12-week treatment
Retention will be defined as the number of participants who completed the 12-week exercise treatment.
Time frame: Baseline to end of 12-week treatment
Compliance will be defined by the proportion of completed treatment sessions.
Time frame: End of 12-week treatment
Acceptability will be recorded by conducting interviews with participants who completed the 12-week exercise treatment.
Time frame: Baseline to end of 12-week treatment
Change in gait speed will be assessed after 12-week exercise treatment.
Time frame: Baseline to end of 12-week treatment
Change in executive function will be assessed after 12-week exercise treatment using Delis-Kaplan Executive Function System.
Contact information is provided by the study sponsor or research team.
VA Office of Research and Development
Fed
Motoric Cognitive Risk Syndrome: Refining Treatment Strategies and Testing Feasibility to Personalize Treatment for Older Veterans
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07586553
Balance, Gait
Balıkesir, Bigadiç, Turkey (Türkiye)
View Trial DetailsNCT07572968
Balance, Dual-Task Performance
Balıkesir, Bigadiç, Turkey (Türkiye)
View Trial DetailsNCT07572942
Cognitive-Motor Interaction, Motoric Cognitive Risk Syndrome
Balıkesir, Bigadiç, Turkey (Türkiye)
View Trial DetailsNCT07045259
Elderly (People Aged 65 or More), Exergaming
Balıkesir, Turkey (Türkiye)
View Trial Details